NewAmsterdam Pharma Co N.V. Cash Flow Statement

Cash Flow Statement Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -6.56M-41.78M-22.63M-176.94M-241.60M
Share-based Compensation 1.24M4.12M24.57M33.62M
Gains from Investment Securities 11.15M15.78M19.03M
Non-cash Items 50.80M297.98M
Cash from Operations -6.82M-29.51M10.66M-141.22M-158.56M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.15M
Amortization of Deferred Charges -0.23M
Depreciation & Amortization (CF) 0.00M0.01M0.01M0.05M0.11M
Change in Working Capital
Change in Receivables -1.55M-5.24M-4.06M
Change in Account Payables 6.56M4.81M5.07M-12.95M
Change in Accured Expenses 0.95M3.14M-8.68M5.47M1.69M
Investing Activities
Capital Expenditures 0.01M0.02M0.22M0.02M0.67M
Cash from Investing Activities -0.01M-0.02M-0.22M-0.02M-62.85M
Financing Activities
Other financing activities 0.52M
Debt Issuance and Repayment
Long-Term Debt Issuances 12.92M
Change in Capital Stock
Shares Issued 84.70M234.60M8.62M13.76M
Misc.
Cash from Financing Activities 12.92M84.70M391.90M8.91M659.51M
Exchange Rate Effect 0.03M-4.68M5.25M5.05M-6.80M
Change in Cash 6.09M55.17M402.35M-132.33M438.10M
Free Cash Flow -6.83M-29.54M10.44M-141.24M-159.24M
Net Cash Flow 6.09M55.17M402.35M-132.33M438.10M